Suramin inhibits growth and transforming growth factor-β1 (TGF-β1) binding in osteosarcoma cell lines

Autocrine Secretion and Malignant Transformation of Cells

Michael B. Sporn, George J. Todaro · New England Journal of Medicine · 1980 · 1.4K citations

Life Sciences, Cancer Biology, Cell Biology +17

TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop

Edouard Battegay, Elaine W. Raines, Ronald A. Seifert et al. · Cell · 1990 · 744 citations

Life Sciences, Cell Biology, Molecular Biology +15

Cartilage-inducing factor-A. Apparent identity to transforming growth factor-beta.

Saeid M. Seyedin, Andrea Y. Thompson, H Bentz et al. · Journal of Biological Chemistry · 1986 · 524 citations · Full text

Medicine, Cell Biology, Developmental Biology +16

Suramin inhibition of growth factor receptor binding and mitogenicity in AKR‐2B cells

Robert J. Coffey, Edward B. Leof, Gary D. Shipley et al. · Journal of Cellular Physiology · 1987 · 380 citations

Life Sciences, Cell Biology, Pharmacology +14

Suramin: an anticancer drug with a unique mechanism of action.

C.A. Stein, R. V. Larocca, Rose V. Thomas et al. · Journal of Clinical Oncology · 1989 · 376 citations

Medicine, Oncology, Pharmacology +13